Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study

NCT02315248 is registered in ClinicalTrials.gov with University of Mississippi Medical Center as lead sponsor.

NCT NCT02315248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02315248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study
Lead sponsor
University of Mississippi Medical Center
Phase
Observational
Overall status
Completed
Start date
December 31, 2014
Completion date
August 31, 2016
Enrollment
197 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis